Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  TiGenix NV    TIG   BE0003864817

TIGENIX NV (TIG)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
01/12/2018 01/15/2018 01/16/2018 01/17/2018 01/18/2018 Date
1.704(c) 1.72(c) 1.724(c) 1.72(c) 1.722(c) Last
7 970 127 1 898 129 3 480 942 2 025 470 1 956 237 Volume
-0.23% +0.94% +0.23% -0.23% +0.12% Change
More quotes
Financials (€)
Sales 2017 -0,13 M
EBIT 2017 -37,4 M
Net income 2017 -41,8 M
Finance 2017 1,00 M
Yield 2017 -
Sales 2018 25,4 M
EBIT 2018 -18,9 M
Net income 2018 -21,6 M
Debt 2018 21,0 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 -3 532x
EV / Sales2018 19,4x
Capitalization 472 M
More Financials
Company
TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products.Its portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells.The company intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial... 
More about the company
Surperformance© ratings of TiGenix NV
Trading Rating : Investor Rating :
More Ratings
Latest news on TIGENIX NV
01/17 TIGENIX : Transparency notifications pursuant to Article 14 of the Law of May 2,..
01/16 TIGENIX : Transparency notifications pursuant to Article 14 of the Law of May 2..
01/15 TIGENIX : Transparency notifications pursuant to Article 14 of the Law of May 2,..
01/15 TIGENIX : announces publication in Gastroenterology of 52-week results of the Ph..
01/15 TIGENIX : announces publication in Gastroenterology of 52-week results of the Ph..
01/12 TIGENIX : Transparency notifications pursuant to Article 14 of the Law of May 2,..
01/12 TIGENIX : Transparency notifications pursuant to Article 14 of the Law of May 2,..
01/12 TIGENIX : Transparency Information
01/11 TIGENIX : Transparency Information (EN - NL)
01/11 TIGENIX : Transparency Information
More news
Sector news : Bio Therapeutic Drugs
01/17 CELGENE : Conducts Deal Talks With Juno -- WSJ
01/16 CELGENE : in Talks to Buy Juno Therapeutics -- Update
01/16 CELGENE : in Talks to Buy Juno Therapeutics
01/12 Drugmakers see a pricing blueprint in an $850,000 gene therapy
01/12 SPARK'S PRICE FOR LUXTURNA BLINDNESS : Icer
More sector news : Bio Therapeutic Drugs
Latest Tweets
01/16$TIG - TiGenix - American Depositary Shares #TIG Lowered to "Neutral" at BTIG.. 
01/16$TIG: TiGenix announces publication of 52-week results of the Phase III ADMIR.. 
01/16TiGenix – American Depositary Shares $TIG Stock Rating Lowered by Zacks Inves.. 
01/15TiGenix – American Depositary Shares $TIG Receiving Positive News Coverage, S.. 
01/15TiGenix announces publication in Gastroenterology of 52-week results of the P.. 
More tweets
Qtime:191
News from SeekingAlpha
01/12 Takeda's Offer On Tigenix - Good Deal Or Not?
2017 TIGENIX : This Stem Cell Pioneer Is Up 40% Since IPO With More Upside To Come
2017 Tigenix Sa reports FY results
2016 IPO PREVIEW : Tigenix
2016 A European Biotech Stock Basket For 2016 - Update
Chart TIGENIX NV
Duration : Period :
TiGenix NV Technical Analysis Chart | TIG | BE0003864817 | 4-Traders
Technical analysis trends TIGENIX NV
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 1,49 €
Spread / Average Target -13%
EPS Revisions
Managers
NameTitle
Eduardo Bravo Fernández de Araoz Chief Executive Officer, Executive Director & MD
Jean Stéphenne Chairman
Claudia D'Augusta Chief Financial Officer & Compliance Officer
Wilfried Dalemans Chief Technical Officer
Marie Paule Richard Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
TIGENIX NV76.95%579
GILEAD SCIENCES12.02%104 801
REGENERON PHARMACEUTICALS-1.53%39 775
VERTEX PHARMACEUTICALS3.90%39 380
GENMAB12.29%11 532
EXELIXIS, INC.-2.47%8 772